Apotex Scientific, Inc

FDA Regulatory Profile

Apotex Scientific, Inc appears in FDA public data with 3 recalls, 1 510(k) clearance, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1435-2016, Class III) was initiated on January 26, 2016. Its most recent 510(k) clearance was granted on August 10, 1993.

Summary

Total Recalls
3
510(k) Clearances
1
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1435-2016Class IIIDuloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, Manufactured by Apotex January 26, 2016
D-1436-2016Class IIIDuloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex January 26, 2016
D-1437-2016Class IIIDuloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles, Rx only, Manufactured by Apotex January 26, 2016

Recent 510(k) Clearances

K-NumberDeviceDate
K932424ANA PROFILE IAugust 10, 1993